Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer
Dong Hoon Shin(National Cancer Center), Sang Soo Kim(National Cancer Center)
Cited by 18
Related Papers
Targets of the Tumor Suppressor <i>miR-200</i> in Regulation of the Epithelial–Mesenchymal Transition in Cancer
|Cancer Research|2011|138
The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL
|Scientific Reports|2016|74
Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin–like Growth Factor I Receptor Monoclonal Antibody
|Molecular Cancer Therapeutics|2011|43
Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors
|Experimental & Molecular Medicine|2018|15
Inhibition of Estrogen Signaling Reduces the Incidence of <i>BRCA1</i>-associated Mammary Tumor Formation
|International Journal of Biological Sciences|2018|12